Preoperative Hydronephrosis Predicts Extravesical and Node Positive Disease in Patients Undergoing Cystectomy for Bladder Cancer

Journal of Urology

Volumn 183, Issue 5, 2010, Pages 1732-1737

  Stimson, C J ^a   Cookson, Michael S ^a   Barocas, Daniel A ^a   Clark, Peter E ^a   Humphrey, John E ^a   Patel, Sanjay G ^a   Smith Jr , Joseph A ^a   Chang, Sam S ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cystectomy; hydronephrosis; mortality; neoplasm staging; urinary bladder neoplasms

Indexed keywords

ADULT; ADVANCED CANCER; ARTICLE; BLADDER CARCINOMA; CANCER SURVIVAL; CONTROLLED STUDY; CYSTECTOMY; FEMALE; HUMAN; HYDRONEPHROSIS; INTRAOPERATIVE PERIOD; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PELVIS LYMPH NODE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

AGED; CHI-SQUARE DISTRIBUTION; CYSTECTOMY; FEMALE; HUMANS; HYDRONEPHROSIS; LOGISTIC MODELS; LYMPHATIC METASTASIS; MALE; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; STATISTICS, NONPARAMETRIC; SURVIVAL RATE; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 77950521284     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2010.01.028     Document Type: Article

References (14)

1. Dinney C.P. Therapy of invasive bladder cancer. Urology 67 (2006) 56
2. Shariat S.F., Palapattu G.S., Karakiewicz P.I., et al. Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy. Eur Urol 51 (2007) 137
3. Ficarra V., Dalpiaz O., Alrabi N., et al. Correlation between clinical and pathological staging in a series of radical cystectomies for bladder carcinoma. BJU Int 95 (2005) 786
4. Grossman H.B., Natale R.B., Tangen C.M., et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 349 (2003) 859
5. Donat S.M. Integrating perioperative chemotherapy into the treatment of muscle-invasive bladder cancer: strategy versus reality. J Natl Compr Canc Netw 7 (2009) 40
6. Chapman D.M., Pohar K.S., Gong M.C., et al. Preoperative hydronephrosis as an indicator of survival after radical cystectomy. Urol Oncol (2008)
7. Canter D., Guzzo T.J., Resnick M.J., et al. Hydronephrosis is an independent predictor of poor clinical outcome in patients treated for muscle-invasive transitional cell carcinoma with radical cystectomy. Urology 72 (2008) 379
8. Bartsch G.C., Kuefer R., Gschwend J.E., et al. Hydronephrosis as a prognostic marker in bladder cancer in a cystectomy-only series. Eur Urol 51 (2007) 690
9. Scrimger R.A., Murtha A.D., Parliament M.B., et al. Muscle-invasive transitional cell carcinoma of the urinary bladder: a population-based study of patterns of care and prognostic factors. Int J Radiat Oncol Biol Phys 51 (2001) 23
10. Yang M.H., Yen C.C., Chen P.M., et al. Prognostic-factors-based risk-stratification model for invasive urothelial carcinoma of the urinary bladder in Taiwan. Urology 59 (2002) 232
11. Bassi P., Ferrante G.D., Piazza N., et al. Prognostic factors of outcome after radical cystectomy for bladder cancer: a retrospective study of a homogeneous patient cohort. J Urol 161 (1999) 1494
12. Thrasher J.B., Frazier H.A., Robertson J.E., et al. Clinical variables which serve as predictors of cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate. Cancer 73 (1994) 1708
13. Haleblian G.E., Skinner E.C., Dickinson M.G., et al. Hydronephrosis as a prognostic indicator in bladder cancer patients. J Urol 160 (1998) 2011
14. Herr H.W., Dotan Z., Donat S.M., et al. Defining optimal therapy for muscle invasive bladder cancer. J Urol 177 (2007) 437